Skip to content

To study the effect of beheda churna vati in cough.

Comparative control clinical study to evaluate efficacy of Bibhitak (Terminalia bellirica) Churn vati in cough - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092836
Enrollment
72
Registered
2025-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Maharashtra University of Health Sciences,Nashik under the scheme of STRG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and females between 18 to 60 years of age (both inclusive) 2. Subject suffering from uncomplicated cough that does not require antibiotic treatment. 3. The onset time should not be more than 3 days. 4. Willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Cough caused by bronchial asthma, tuberculosis, bronchiectasis, and other diseases that have been clearly diagnosed as chronic obstructive pulmonary disease and/or severe respiratory tract infection. 2. Patient with known current lung cancer and fibrosis of lung. 3. Patients with uncontrolled diabetes or hypertension. 4. Women during pregnancy or lactation or women who are preparing for pregnancy or lactation during the trial. 5. Subjects with known current serious illness, eg, multisystem failure, chronic liver disease, HIV, cancer, renal failure, serious cardiovascular disease. 6. Known allergy to any ingredient of study products. 7. Any other conditions, which in the opinion of the investigator/s, makes the patient unsuitable for enrollment or could interfere with his/her participation and completion of the study.

Design outcomes

Primary

MeasureTime frame
1)To study the Anti-inflammatory effect of Bibhitak Churna Vati in pharyngitis having Cough.Timepoint: 1 week

Secondary

MeasureTime frame
1) To study soothing effect of Bibhitak Churna Vati in Cold. 2) To assess the effect of Bibhitak Churna Vati in dry and wet cough. 3) To study the anti microbial properties of Bibhitak Churna Vati in Cough. Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Shishir P Pande

Ayurved Seva Sangh Ayurved Mahavidyala, Ganeshwadi ,Panchavati ,Nashik- 03

shishir.nsk@gmail.com9420830818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026